Updated 8/29/2022. The results chart includes audits where the findings have been finalized. Remaining audits are still under review. Information on Corrective Action Plans and Sanctions will be updated once approved by HRSA. HRSA recommends covered entities do not contact audited manufacturers regarding sanctions until a corrective action plan has been approved by HRSA and posted on this website.
| Manufacturer Sort descending | Labeler Codes Reviewed | State | OPA Findings | Sanction | Corrective Action Status |
|---|---|---|---|---|---|
Akorn, Inc.Contact InformationChief Commercial Officer |
17478 49411 50383 61748 |
IL |
1. Akorn did not determine the difference between new drug price estimates and actual 340B ceiling price and offer a refund. 2. Akorn did not submit quarterly pricing data to 340B OPAIS. |
Repayment to covered entities |
CAP implemented Audit closure date: April 26, 2022 |
BioComp PharmaContact InformationCompliance Coordinator – Medicaid |
44523 00178 |
TX |
BioComp did not offer covered outpatient drugs to eligible covered entities at the statutory ceiling price. |
Repayment to covered entities |
CAP implemented Audit closure date: August 16, 2022 |
Chain Drug Marketing AssociationContact InformationMedicaid Specialist 248-465-0670 W 9 Mile Road Novi, MI 48375 donnan@chaindrug.com |
63868 | MI |
1. CDMA did not offer covered outpatient drugs to eligible covered entities at the statutory ceiling price. 2. CDMA did not submit quarterly pricing data to 340B OPAIS. |
Repayment to covered entities |
CAP implemented Audit closure date: |
| Neos Therapeutics |
70165 62542 |
TX |
No adverse findings |
None |
N/A |
TAGI Pharma, Inc.Contact InformationTAGI Pharma, Inc.: Precision Dose, Inc.: |
51224 68094 |
IL |
1. Precision Dose charged more than the 340B ceiling price. 2. Precision Dose did not determine the difference between new drug price estimates and actual 340B ceiling price and offer a refund. 3. Tagi and Precision dose did not submit quarterly pricing data to 340B OPAIS. |
Repayment to covered entities |
CAP implemented Audit closure date: May 20, 2022 |